GAMMAHV68 VMAP MITOCHONDRIAL ANTI-APOPTOSIS PROTEIN
GAMMAHV68 VMAP MITOCHONDRIAL ANTI-APOPTOSIS PROTEIN
批准号:
7562107
负责人:
Pinghui Feng
金额:
$3.16万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-05-01 至 2008-04-30
关键词:
Amphipathic Alpha HelixApoptosisApoptoticAvidityC-terminalCellsComputer Retrieval of Information on Scientific Projects DatabaseFundingGene ProteinsGrantHerpesviridaeInstitutionMediatingMitochondriaMusN-terminalNormal CellProcessProteinsReportingResearchResearch PersonnelResourcesSimplexvirusSourceUnited States National Institutes of HealthVDAC1 geneViralVirusVirus Diseasescytochrome clytic replicationnovel
中文摘要
这个子项目是许多研究子项目中利用
资源由NIH/NCRR资助的中心拨款提供。子项目和
调查员(PI)可能从NIH的另一个来源获得了主要资金,
并因此可以在其他清晰的条目中表示。列出的机构是
该中心不一定是调查人员的机构。
一旦病毒感染,细胞就会发生凋亡,以防御病毒复制。反过来,病毒进化出了复杂的机制来颠覆细胞凋亡的过程。在这里,我们报道了一种新的小鼠伽马疱疹病毒68(GammaHV68)的病毒线粒体抗凋亡蛋白(VMAP)与Bcl2和VDAC1以基因和功能分离的方式相互作用。VMAP的N端两亲性α-螺旋区域与Bcl2相互作用,这种相互作用不仅显著增加了Bcl2对线粒体的募集,而且显著增加了其对BH3促凋亡蛋白的亲和力,从而抑制了Bax线粒体的移位和激活。此外,VMAP的中心疏水区和C末端疏水区与VDAC1相互作用,有效地抑制细胞色素c的释放。因此,这些相互作用导致对线粒体介导的细胞凋亡的全面抑制。最后,在正常细胞中,VMAP基因是有效的GammaHV68裂解复制所必需的,但在线粒体凋亡缺陷的细胞中不是。
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Upon viral infection, cells undergo apoptosis as a defense against viral replication. Viruses, in turn, have evolved elaborate mechanisms to subvert apoptotic processes. Here, we report that a novel viral mitochondrial anti-apoptotic protein (vMAP) of murine gamma-herpesvirus 68 (gammaHV68) interacts with Bcl-2 and VDAC1 in a genetically and functionally separable manner. The N-terminal amphipathic alpha-helix region of vMAP interacted with Bcl-2 and this interaction markedly increased not only Bcl-2 recruitment to mitochondria but also its avidity for BH3-only proapoptotic proteins, thereby suppressing Bax mitochondrial translocation and activation. In addition, the central and C-terminal hydrophobic regions of vMAP interacted with VDAC1, resulting in effective inhibition of cytochrome c release. Consequently, these interactions induced the comprehensive inhibition of mitochondrion-mediated apoptosis. Finally, vMAP gene was required for efficient gammaHV68 lytic replication in normal cells, but not in mitochondrial apoptosis-deficient cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting IKKepsilon-mediated nucleotide synthesis in KSHV-associated lymphoma
-
批准号:10762816
-
项目类别:
-
资助金额:$37.86万
-
财政年份:2023
-
负责人:Pinghui Feng
-
依托单位:
Explore roles of HSV-1 in Alzheimer's disease using mouse models
-
批准号:10629403
-
项目类别:
-
资助金额:$79.9万
-
财政年份:2021
-
负责人:Pinghui Feng
-
依托单位:
Exploring roles of protein deamidation in oral inflammation
-
批准号:9752511
-
项目类别:
-
资助金额:$104.23万
-
财政年份:2017
-
负责人:Pinghui Feng
-
依托单位:
Exploring roles of protein deamidation in oral inflammation
-
批准号:9461929
-
项目类别:
-
资助金额:$67.72万
-
财政年份:2017
-
负责人:Pinghui Feng
-
依托单位:
NFAT activation in kGPCR tumorigenesis
-
批准号:9410699
-
项目类别:
-
资助金额:$37.74万
-
财政年份:2017
-
负责人:Pinghui Feng
-
依托单位:
NFAT activation in kGPCR tumorigenesis
-
批准号:10251852
-
项目类别:
-
资助金额:$37.74万
-
财政年份:2017
-
负责人:Pinghui Feng
-
依托单位:
Targeting an immune kinase to purge KSHV latent infection
-
批准号:9116597
-
项目类别:
-
资助金额:$67.66万
-
财政年份:2016
-
负责人:Pinghui Feng
-
依托单位:
Targeting an immune kinase to purge KSHV latent infection
-
批准号:9242614
-
项目类别:
-
资助金额:$67.66万
-
财政年份:2016
-
负责人:Pinghui Feng
-
依托单位:
A recombinant virus approach for gamma herpesvirus oncogenesis
-
批准号:8638543
-
项目类别:
-
资助金额:$24.63万
-
财政年份:2013
-
负责人:Pinghui Feng
-
依托单位:
Proviral Roles of an Innate Immune Pathway
-
批准号:8184241
-
项目类别:
-
资助金额:$40.75万
-
财政年份:2011
-
负责人:Pinghui Feng
-
依托单位:
Protein Deamidation in Innate Immune Evasion Regulated by Viral Pseudo Enzymes
-
批准号:9381580
-
项目类别:
-
资助金额:$45.48万
-
财政年份:2011
-
负责人:Pinghui Feng
-
依托单位:
Proviral Roles of an Innate Immune Pathway
-
批准号:8846572
-
项目类别:
-
资助金额:$41.25万
-
财政年份:2011
-
负责人:Pinghui Feng
-
依托单位:
Proviral Roles of an Innate Immune Pathway
-
批准号:8326568
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2011
-
负责人:Pinghui Feng
-
依托单位:
Proviral Roles of an Innate Immune Pathway
-
批准号:8469753
-
项目类别:
-
资助金额:$39.36万
-
财政年份:2011
-
负责人:Pinghui Feng
-
依托单位:
Post-Translational Events Underlying the KSHV vGPCR Pathogenesis
-
批准号:8246529
-
项目类别:
-
资助金额:$32.98万
-
财政年份:2009
-
负责人:Pinghui Feng
-
依托单位:
Post-Translational Events Underlying the KSHV vGPCR Pathogenesis
-
批准号:8060647
-
项目类别:
-
资助金额:$10.04万
-
财政年份:2009
-
负责人:Pinghui Feng
-
依托单位:
Post-Translational Events Underlying the KSHV vGPCR Pathogenesis
-
批准号:8460123
-
项目类别:
-
资助金额:$31.03万
-
财政年份:2009
-
负责人:Pinghui Feng
-
依托单位:
Post-Translational Events Underlying the KSHV vGPCR Pathogenesis
-
批准号:7755457
-
项目类别:
-
资助金额:$31.39万
-
财政年份:2009
-
负责人:Pinghui Feng
-
依托单位:
Post-Translational Events Underlying the KSHV vGPCR Pathogenesis
-
批准号:8367335
-
项目类别:
-
资助金额:$22.4万
-
财政年份:2009
-
负责人:Pinghui Feng
-
依托单位:
INHIBITION OF MITOCHONDRION-DEPENDENT APOPTOSIS BY HERPESVIRAL PROTEIN
-
批准号:7715509
-
项目类别:
-
资助金额:$3.24万
-
财政年份:2008
-
负责人:Pinghui Feng
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: